First Approved CAR T-Cell Therapy Shows Continued Benefits Five Years Later
Jun 16, 2022
New data on show CAR T-cell therapy leads to durable remission and long-term survival in children and young adults with relapsed or refractory B-ALL.
Cancer Center News
Your child will be cared for by one of the most accomplished teams of childhood cancer experts in the world. We provide medical care, emotional counseling and much more. We make sure your child, you and every family member get the highest level of support.
Existing patients or family members
New patients, referrals and second opinions
New Data Show Benefits of CRISPR-edited Gene Therapy for Blood Disorders in a Larger Patient Group with Longer-Term Follow-Up
Jun 14, 2022
A group of researchers that includes CHOP presented new data on CRISPR-edited gene therapy for blood disorders at an international meeting.
CHOP Researchers Uncover Molecular Basis of Antigen Processing for Cancer Target MR1
Jun 20, 2022
CHOP researchers have revealed the molecular mechanics of a cell-surface molecule that is a potential immunotherapy target.
Tribeca Film Festival to Debut Documentary Tracing the Path to Penn Medicine and Children’s Hospital of Philadelphia’s Transformative, Personalized Cancer Therapy
Jun 9, 2022
"Of Medicine and Miracles” details the journey of a team of doctors and a family who came together on the leading edge of a cancer cure.
Dr. Peter Phillips Presented with the Alex’s Lemonade Stand Foundation Pitcher of Hope Award
Jun 8, 2022
Dr. Peter Phillips, former Section Chief of Neuro-Oncology of our Cancer Center, was recently given the Alex’s Lemonade Stand Foundation (ALSF) Pitcher of Hope Award, which honors someone at CHOP who has gone above and beyond to make an impact on the lives of the children treated in the Oncology Department.
Penn Medicine and Children’s Hospital of Philadelphia Announce Partnership with Costa Rica for CAR T Cell Therapy
May 23, 2022
International collaboration aims to ensure more equitable access to transformative personalized cancer therapy.
CHOP Researchers Develop Allogeneic CART for Relapsed or Refractory T-ALL Using Base Editing
May 23, 2022
CHOP researchers have tested and developed an “off-the-shelf” chimeric antigen receptor T-cell (CART) using base editing.
First Child to Receive Revolutionary CAR T Therapy Celebrates 10 Years Cancer Free
May 11, 2022
Emily Whitehead, now 17, received life-saving treatment at CHOP, transforming the field of cancer immunotherapy.
Emily Whitehead, First Pediatric Patient to Receive CAR T-Cell Therapy, Celebrates Cure 10 Years Later
May 11, 2022
Whitehead received life-saving treatment at CHOP, under the care of Dr. Stephan Grupp, transforming the field of cancer immunotherapy.
CHOP Oncologists Recognized at 2022 ASPHO Conference
May 5, 2022
Drs. Yael Mossé and Sogol Mostoufi-Moab were recognized at the 2022 ASPHO Conference for their outstanding contributions in the field of pediatric oncology.